Type 1 diabetes (T1D) is an autoimmune condition where the body cannot produce insulin properly, and this can affect the life ...
A recent survey found that more than half of adults living with Type 1 diabetes believe the condition limits their ability to be spontaneous ...
"Adherence improves when treatment integrates easily into patients’ lives," explains Adam McBride, Eden’s CEO. Eden’s digital ...
Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...
A new survey has found that Type 1 diabetes can affect everyday decisions for nearly a third of those diagnosed ...
A recent survey found that more than half of people living with Type 1 diabetes say the condition has an impact on their ...
The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 ...
The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 ...
MORE than half of adults living with type 1 diabetes believe the condition stops them from being more spontaneous. A poll of ...
Q1 2025 Earnings Call Transcript February 6, 2025 Embecta Corp. beats earnings expectations. Reported EPS is $0.65, ...
Embecta Corp (EMBC) reports a mixed quarter with revenue declines but strong growth in safety products and contract manufacturing, while focusing on debt reduction and strategic partnerships.